By Chelsea Naso ( June 17, 2015, 8:28 PM EDT) -- Venture capital-backed Nivalis Therapeutics Inc. roared onto the market Wednesday after topping expectations for its initial public offering, making it the latest life sciences company to spark investor interest as a robust acquisition environment adds fuel to the red-hot IPO market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.